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Abstract
Heparan sulfate (HS) plays essential roles in assisting herpes simplex virus infection and other
biological processes. The biosynthesis of HS includes numerous specialized sulfotransferases that
generate a variety of sulfated saccharide sequences, conferring the selectivity of biological
functions of HS. We report a structural study of human HS 3-O-sulfotransferase isoform 3 (3-
OST-3), a key sulfotransferase that transfers a sulfuryl group to a specific glucosamine in HS
generating an entry receptor for herpes simplex virus 1. We have obtained the crystal structure of
3-OST-3 at 1.95 Å in a ternary complex with 3′-phosphoadenosine 5′-phosphate and a
tetrasaccharide substrate. Mutational analyses were also performed on the residues involved in the
binding of the substrate. Residues Gln255 and Lys368 are essential for the sulfotransferase activity
and lie within hydrogen bonding distances to the carboxyl and sulfo groups of the uronic acid unit.
These residues participate in the substrate recognition of 3-OST-3. This structure provides atomic
level evidence for delineating the substrate recognition and catalytic mechanism for 3-OST-3.
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Heparan sulfate (HS)1 is ubiquitous on the cell surface and in the extracellular matrix. It has
diverse roles in regulating embryonic development and homeostasis as well as in assisting
viral infections (1, 2). HS is a highly sulfated polysaccharide consisting of 1→4-linked
sulfated glucosamine and sulfated glucuronic/iduronic acid units. HS is initially synthesized
as a copolymer of glucuronic acid and N-acetylated glucosamine by D-glucuronyl and N-
acetyl-D-glucosaminyltransferase, followed by various modifications in the Golgi apparatus
(3). These modifications include N-deacetylation and N-sulfonation of glucosamine, C5
epimerization of glucuronic acid to form iduronic acid units, 2-O-sulfonation of iduronic and
glucuronic acid units, and 6-O-sulfonation and 3-O-sulfonation of glucosamine units. The
specific sulfated saccharide sequences of HS determine its biological function (4).
Infections caused by herpes simplex virus type 1 (HSV-1) are highly prevalent in human and
result in localized mucocutaneous lesions and, in rare cases, encephalitis (5). HS plays
critical roles in assisting HSV-1 infections in both viral attachment and entry steps (6). In
the attachment step, HSV-1 binds to the cells through the interactions of envelope
glycoproteins gC or/and gB with cell surface HS (7). Viral entry requires the interaction of a
third viral glycoprotein, gD, with a specific cell surface entry receptor to induce fusion of
the viral envelope with the cell membrane (in the presence of gB, gH, and gL) to establish
an infection (8). The 3-O-sulfated HS, representing the culmination of a series of specific
sulfated saccharide sequences, binds to gD and serves as an entry receptor of HSV-1 (9, 10).
The 3-O-sulfated HS is synthesized by heparan sulfate 3-O-sulfotransferase isoform 3 (3-
OST-3) and by 3-OST-5 (9, 10). A gD-binding HS octasaccharide was isolated and
characterized, confirming that HSV-1 utilizes a unique HS sequence for its entry (11).
Understanding the biosynthesis of 3-O-sulfated HS could potentially lead to a new strategy
for developing therapeutic agents against HSV infection.
HS 3-O-sulfotransferase is present in at least six different isoforms with unique expression
patterns in human tissues (10, 12). The amino acid sequences of the different isoforms have
greater than 60% homology in the sulfotransferase domains (12). These different 3-OST
isoforms transfer the sulfuryl group from 3′-phosphoadenosine 5′-phosphosulfate (PAPS) to
the 3-OH position of glucosamine units residing within the context of different saccharide
sequences. As a result, the HS products generated by these different isoforms exhibit unique
and distinctive biological activities (Fig. 1A). It is known that the HS modified by 3-OST-1
and 3-OST-5 displays anticoagulant activity. The HS modified by 3-OST-3 and 3-OST-5
serves as an entry receptor for HSV-1 (9, 10, 13). The molecular mechanism used by 3-
OSTs to distinguish substrates with unique saccharide sequences remains largely unknown.
Previously, x-ray crystal structures have been obtained for the sulfotransferase domains of
human N-deacetylase/N-sulfotransferase (NST-1) and mouse 3-OST-1 in the complex with
3′-phosphoadenosine 5′-phosphate (PAP) (14, 15). The structural information combined
with the results of mutational analysis provided us with preliminary insight into the HS
sulfotransferase mechanism (14, 16). Furthermore, potential roles of specific amino acid
1The abbreviations used are: HS, heparan sulfate; HSV-1, herpes simplex virus type 1; 3-OST-3, 3-O-sulfotransferase isoform 3;
PAPS, 3′-phosphoadenosine 5′-phosphosulfate; NST, N-sulfotransferase; PAP, 3′-phosphoadenosine 5′-phosphate; Tricine, N-[2-
hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; MES, 4-morpholineethanesulfonic acid; HPLC, high pressure liquid chromatography;
GlcUA, glucuronic acid.
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residues from NST-1 and 3-OST-1 for directing the transfer of the sulfuryl group were
suggested (14). However, because these structures lacked acceptor substrate, they have
provided limited knowledge to our understanding of what dictates HS binding, in particular,
among the 3-OST isoforms.
In this study, we report the crystal structure of a ternary complex of human 3-OST-3, PAP,
and a tetrasaccharide substrate with the structure of δUA2S-GlcNS6S-IdoUA2S-GlcNS6S
(for structure see Fig. 1B). This ternary complex structure, combined with the mutagenesis
data presented here, reveals the residues involved in catalysis and in substrate binding. The
data provide structural evidence for which residues confer substrate specificity between the
3-OST isoforms. These results present new insight into the biosynthesis of the HS with
various biological functions ranging from viral infection to blood coagulation.
EXPERIMENTAL PROCEDURES
Expression, Purification, and Crystallization of 3-OST-3
Preparation of 3-OST-3 Bacterial Expression Plasmid—The cDNA fragment
encoding the catalytic domain of 3-OST-3 (Gly139–Gly406) was amplified from plasmid h3-
OST-3A-pcDNA3 (17) with a 5′ overhang containing an EcoRI site and a 3′ overhang
containing an NotI site. This construct was inserted into the pGEX4T3 vector (Amersham
Biosciences) using the EcoRI and NotI restriction sites to produce a glutathione S-
transferase fusion protein. The resultant plasmid was sequenced to confirm the reading
frame and the lack of mutations within the coding region (University of North Carolina,
DNA sequencing core facility). The plasmid was transformed into BL21(DE3)RIL cells
(Stratagene).
Protein Expression and Purification—Cells containing the expression plasmid were
grown in twelve 2.8-liter Fernbach flasks containing 1 liter of LB medium with 100 μg/ml of
ampicillin at 37 °C. When the A600 reached 0.6–0.8, the temperature was lowered to 22 °C
for 15 min. Isopropyl-β-D-thiogalactopyranoside was then added to a final concentration of
200 μM, and the cells were allowed to shake overnight. The cells were pelleted and
resuspended in 120 ml of sonication buffer (25 mM sodium/potassium phosphate, pH 7.4,
and 625 mM NaCl). The cells were sonicated, and the cell debris was pelleted by
centrifugation. The soluble fraction was loaded onto 20 ml of glutathione-Sepharose 4B
(Amersham Biosciences) resin in batch and washed repeatedly with sonication buffer. The
catalytic domain of 3-OST-3 was cleaved from the fusion protein on the resin at 4 °C
overnight using 400 units of thrombin in a total volume of 50 ml. PAP (Sigma) was added to
the solution for a final concentration of 0.5 mM. The protein was concentrated to ~35
mg/ml. Protein was further purified by a Superdex 75 16/60 (Amersham Biosciences)
column. The eluted fractions containing pure 3-OST-3 were pooled. The buffer was
exchanged with the crystallization buffer (20 mM Tris, pH 7.5, 100 mM NaCl, and 1 mM
PAP) by repeated concentration and dilution. The final concentration of the protein was 10
mg/ml, and additional PAP was added for a final concentration of 4 mM.
Protein Crystallization, Data Collection, and Structure Solution—Crystals of the
catalytic domain of 3-OST-3 were obtained using the hanging drop method by mixing 2 μl
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of the above protein solution with 2 μl of the reservoir solution consisting of 12–13%
polyethylene glycol 4000, 200 mM ammonium acetate, and 100 mM sodium citrate, pH 5.5.
For data collection, the crystals were transferred in four steps into a cryo-protectant
consisting of 15% polyethylene glycol 4000, 12.5% ethylene glycol, 4 mM PAP, 200 mM
ammonium acetate, 100 mM NaCl, and 100 mM sodium citrate, pH 5.5. To obtain the
ternary complex, the crystal was soaked overnight in cryo-protectant containing 20 mM of
the tetrasaccharide. The crystals were frozen in liquid nitrogen and then placed in a stream
of nitrogen gas cooled to −180 °C. The data were collected on a Rigaku RU3H generator
fitted with Osmic mirrors and a Raxis IV area detector. The data were indexed, integrated,
and scaled using HKL2000 (18). Coordinates from the 3-OST-1 isoform (Protein Data Bank
code 1S6T) were used to find a solution for the molecular replacement problem using the
program Molrep from CCP4 (19, 20). The model of 3-OST-3 was refined by iterative cycles
of model building in O (21) and refinement in CNS (22). The starting model for the
tetrasaccharide was obtained from the Protein Data Bank coordinates 1BFB (23).
Mutational Analysis of 3-OST-3
Preparation of 3-OST-3 Mutant Plasmids—The cDNA fragment encoding the
catalytic domain of 3-OST-3 (Gly139–Gly406) was amplified from plasmid h3-OST-3A-
pcDNA3 (17) with a 5′ overhang containing an NdeI site and a 3′ overhang containing an
EcoRI site. This construct was inserted into the pET28a vector (Novagen) using the NdeI
and EcoRI restriction sites to produce a His6-tagged protein. The mutants were prepared
using Gene Tailor site-directed mutagenesis kit from Invitrogen as described elsewhere (14).
Expression and Characterization of 3-OST-3—The procedures for the expression and
purification of 3-OST-3 were essentially identical to those for 3-OST-1 as described in a
prior publication (14). To confirm that bacterial 3-OST-3 has similar activity to the protein
expressed in SF9 cells, we conducted a kinetic analysis to determine the Km and Vmax
toward PAPS and HS, respectively. The Km and Vmax toward PAPS of the 3-OST-3
expressed in Escherichia coli is 40 μM and 27 pmol of sulfate/min, respectively, which are
close to the Km value (16 μM) and Vmax value (27 pmol of sulfate/min) of the 3-OST-3
expressed in SF9 cells. The Km and Vmax toward HS of the 3-OST-3 expressed in E. coli is
2.5 μM and 24 pmol of sulfate/min, respectively, which are close to the Km (1 μM) and Vmax
(21 pmol of sulfate/min) of the 3-OST-3 expressed in SF9 cells.
Expression and Purification of 3-OST-3 Mutants—The expression plasmids for
various 3-OST-3 mutants were transformed individually into BL21(DE3)RIL cells
(Stratagene). Each mutant construct was grown in 500 ml of LB broth and induced by
isopropyl-β-D-thiogalactopyranoside. The bacteria were harvested and sonicated. The lysate
was subjected to a 400-μl nitrilotriacetic acid-agarose column (0.75 cm × 1 cm), followed by
5 ml of wash with 10 mM imidazole, 25 mM Tris, and 500 mM NaCl, pH 7.5. Mutant
proteins were eluted with 1 ml of elution buffer containing 25 mM Tris, 500 mM NaCl, and
250 mM imidazole, pH 7.5. Approximately 25 μl of the eluent was subjected to the analysis
on a 16.5% Tris-Tricine-PAGE gel (Bio-Rad), and the gel was stained by Coomassie Blue.
The expression level of the mutant protein was estimated by determining the intensity of the
Coomassie-stained protein band near 30 kDa. Wild type 3-OST-3 was expressed along with
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the mutants. The expression levels and the sulfotransferase activity of mutant proteins were
normalized to those of wild type protein.
Determination of the Sulfotransferase Activity—Sulfotransferase activity was
determined by incubating ~5 μl (10 –100 ng) of purified mutant or wild type 3-OST-3
proteins with 10 μg of HS (from bovine kidney; ICN), 5 × 106 cpm of [35S]PAPS (~10 μM)
in 50 μl of buffer containing 50 mM MES, pH 7.0, 10 mM MnCl2, 5 mM MgCl2, and 1%
Triton X-100. The reaction was incubated at 37 °C for 60 min and quenched by the addition
of 6 M urea and 100 mM EDTA. The sample was then subjected to 200-μl DEAE-Sepharose
chromatography to purify the [35S]HS.
Disaccharide Analysis of the HS Modified by Wild Type 3-OST-3 and 3-OST-3
Mutants—3-OST-3-modified HS was degraded with nitrous acid at pH 1.5, followed by
reduction with sodium borohydride (24). The resultant 35S-labeled disaccharides were
resolved by a C18 reversed phase column (0.46 × 25 cm) (Vydac) under reversed phase ion
pairing HPLC conditions. The identities of the disaccharides were determined by coeluting
with appropriate 35S-labeled disaccharide standards (25).
Determination of 3-O-[35S]Sulfonation Site on the Tetrasaccharide
We utilized a combination of the digestions of heparin lyase and δ4,5-glycuronate-2-sulfatase
to determine the 3-O-[35S]sulfonation site. The 3-O-[35S]sulfated tetrasaccharide was
prepared by incubating 3-OST-3 enzyme, the tetrasaccharide, and [35S]PAPS. The resultant
3-O-[35S]sulfated tetrasaccharide was eluted from the anion exchange HPLC column at a
salt concentration consistent with the introduction of one additional sulfo group. Heparin
lyase cleaves the glycosidic bond between G3 and I2 of the 3-O-[35S]sulfated
tetrasaccharide to yield two disaccharides, δUA2S-[3-35S]GlcNS3S6S and δUA2S-GlcNS6S
(unlabeled) (illustrated in Fig. 5) (26). To this point, it is not possible to distinguish whether
the 3-O-[35S]sulfo group was originally on the G3 or G1 unit of the original tetrasaccharide
because the digestion would yield an identical 35S-labeled disaccharide for both cases.
Pretreatment of 3-O-[35S]sulfated tetrasaccharide with δ4,5-glycuronate-2-sulfatase,
however, removes the 2-O-sulfo group from the U4 unit (27) to yield δUA unit at the
nonreducing end (U4 unit). Subsequent treatment with heparin lyase (a mixture of heparin
lyase I, II, and IV were used because of the reported resistance of small oligosaccharides to
heparin lyases (26)) afforded the δUA-[3-35S]GlcNS3S6S consistent with the presence of
the 3-O-[35S]sulfo group on the G3 residue, the 35S-labeled disaccharide with a structure of
δUA2S-[3-35S]GlcNS3S6S would be obtained if the 3-O-[35S]sulfo group is on the G1
residue. The resultant disaccharides were identified by determining the elution positions on
an anion exchange HPLC using an on-line radioactive detector.
The conditions for δ4,5-glycuronate-2-sulfatase digestion are described elsewhere (11).
Digestion with heparin lyase of the tetrasaccharide was carried out using a mixture of
heparin lyase I, II, and IV. The digestion condition for the mixture of heparin lyases was
described in a prior publication (11). The anion exchange HPLC was performed on a silical
based amino-bound anion exchange HPLC (0.46 × 24 cm; Waters) eluted with a linear
gradient of KH2PO4 (300–1000 mM in 60 min) followed by 1 M KH2PO4 for an additional
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20 min at a flow rate of 0.5 ml/min. We noted that this 3-O-sulfated tetrasaccharide is
resistant to nitrous acid (at pH 1.5) degradation.
RESULTS AND DISCUSSION
Crystal Analysis
Human 3-OST-3 crystallizes in space group C2221 and diffracts to 1.85 Å resolution. Two
molecules were present in the asymmetric unit (molecules A and B), and each protein
molecule contains one molecule of PAP. The crystals of 3-OST-3 are densely packed,
generating a unit cell with a Matthews coefficient of 2.0 and an overall solvent content of
38.5% (28). Both molecules in the asymmetric unit are well ordered and have similar B-
factors (Table I). The data were collected on a similar crystal soaked in the tetrasaccharide at
1.95 Å. One of the two molecules in the asymmetric unit has clear electron density for the
tetrasaccharide that allows for precise positioning. The other molecule has some electron
density in the binding pocket region, but it is not clear enough to model.
Overall Fold
The catalytic domain of human 3-OST-3 (Gly139–Gly406) is roughly spherical with a large
open cleft running across the surface of the sphere (Fig. 2). At the core of the sphere is an
α/β motif. This α/β motif is comprised of a five-stranded parallel β-sheet (β7-β6-β2-β5-β3),
laterally flanked by α-helices. Central to this structural motif is the phosphosulfate-binding
loop (K162-R166), contained within a strand-loop-helix comprised of β2 and α2 (29). The
phosphosulfate-binding loop allows for several strong hydrogen bonding interactions with
the 5′-phosphate of PAP (Fig. 3 and Table II). These interactions are believed to help
position the donor substrate, PAPS, in the precise location for catalysis (30). This binding
site is well conserved with the previously reported 3-OST-1 and NST-1 (14, 15). The 5′-
phosphate of PAP is found at the bottom of the large open cleft that provides the binding
pocket for HS substrate (Figs. 2 and 3). A conserved α-helix (α5) composed of residues
Ala244–Lys259 is positioned in close proximity to the PAP-binding site and protrudes
outward into the open cleft. The C-terminal region of the protein contains a small three-
stranded anti-parallel β-sheet (β8-β9-β10). The second and third strands of this sheet are
structurally reinforced by a disulfide bond between residues Cys351 and Cys363. Strand 10 of
this sheet is connected to the C-terminal β-helix (β11) via a long coil (Lys366–Arg377) that
lies along one side of the open cleft, partially obscuring the PAP-binding site.
The structure of 3-OST-3 is remarkably similar to that of 3-OST-1, with a root mean square
deviation of 1.1 Å for 246 equivalent Cα atoms as calculated by the software program O
(14, 21), although some minor differences present within looped regions were notable (Fig.
2). In contrast to 3-OST-1, 3-OST-3 has an insertion of three amino acids (Ala355–Gly357)
into the loop formed by the disulfide bond between Cys351 and Cys363 in strands 9 and 10 of
the C-terminal β-sheet. These additional residues cause the loop to swing in the direction of
the open cleft. Replacing the disulfide bond loop regions of 3-OST-1 (Cys260–Cys269) with
the sequence of 3-OST-3 (Cys351–Cys363) has no effect on the substrate specificity of 3-
OSTs (data not shown). This finding suggests that this loop structure does not directly
contribute to the substrate specificity of 3-OST-1 and 3-OST-3. Another notable difference
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between 3-OST-1 and 3-OST-3 is the presence of a N-terminal α-helix, Pro136–Glu147
(residues Pro136–Ser138 are cloning artifacts from the expression vector), found in 3-OST-3.
This helix packs along the side of the protein in a shallow groove formed by the C-terminal
three-stranded β-sheet of a neighboring molecule in the crystal. However, it is external to the
conserved sulfotransferase domain.
Tetrasaccharide-binding Site
The structure of the protein with bound substrate is virtually identical to that of the apo-
protein with respect to the backbone positions. A small number of side chains were altered
upon substrate binding, most of which are found in or near the HS-binding site. The
tetrasaccharide (δUA2S-GlcNS6S-IdoUA2S-GlcNS6S; Fig. 1B) binds in an extended
conformation along the open cleft. This position places the 3-OH group of the glucosamine
unit (G3) in close proximity to the PAP-binding site within the open cleft. It is interesting to
note that the tetrasaccharide appears to behave rather like two distinct disaccharide units
(Fig. 4). The two units on the reducing end (I2-G1) have fewer potential hydrogen bonding
partners than those (U4-G3) on the nonreducing end and thus are more disordered and
consequently have higher B-factors (Table I). In addition, the sugar rings of U4-G3 lie in the
same plane that is rotated almost 90° around the α(1→4) glycosidic bond, with respect to
the plane of the sugar rings of I2-G1. A similar twist has been previously observed in the
basic fibroblast growth factor/HS structure (23).
The saccharide that forms the most extensive interactions with the protein is the uronic acid
(U4) (Fig. 4, a and b, Table IV). This observation suggests that this sugar unit contributes
significantly to the substrate specificity for 3-OST-3. Residues Gln255, Lys259, and Arg370
are all within hydrogen bonding distance to the 2-O-sulfo group. Residues Arg166, Lys215,
and Lys368 are all within hydrogen bonding distance to the carboxyl group (Table IV). In
addition to interactions with the charged groups, the hydroxyl from residue Thr367 is within
hydrogen bonding distance to the 3-OH of U4. It should be noted that δ4,5 unsaturated 2-O-
sulfo uronic acid (δUA2S or U4 in this tetrasaccharide), a product of heparin lyase digestion,
is a saturated saccharide unit (in the form of 2-O-sulfo iduronic acid, or IdoUA2S) in HS
polysaccharide. The 2So conformation of 2-O-sulfo iduronic acid and the 2H1 (31)
conformation of δUA2S (U4) unit allow similar positioning of the 2-O-sulfo, 3-OH, and 5-
carboxyl groups. Thus, the δUA2S mimics IdoUA2S sufficiently well to be recognized by 3-
OST-3. Furthermore, the solution conformation of this tetrasaccharide indicates that neither
the I2 or U4 units substantially modify the conformations of the adjacent G1 and G3 residue
(31). Indeed, this tetrasaccharide is a substrate for 3-OST-3 as described below.
The G3 unit appears to be the acceptor site of sulfonation. This unit is present in a 4C1
conformation, and its 3-OH is positioned within hydrogen bonding distance to the glutamate
residue (Glu184) (Table IV). It has been demonstrated that the equivalent residue in similar
enzymes functions as the catalytic base (14, 16). A less ordered sulfo group at the C-6
position was observed, suggesting that it is not essential for substrate specificity. This
observation is consistent with results from biochemical studies of 3-OST-3 (11, 25). The N-
sulfo group is in a position to form a hydrogen bond with the backbone amide of Ser218. It
has been determined that 3-OST-3 sulfonates an N-unsubstituted glucosamine unit at the
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polysaccharide level (Fig. 1A) (25). Both glucosamine units (G1 and G3) are N-sulfonated
(Fig. 1B) in the tetrasaccharide used in this experiment. Furthermore, the N-sulfo group was
well ordered in a confined pocket, although no positively charged amino acid residues are
found nearby. The restricted location of the N-sulfo group is perhaps due to the fact that the
acceptor 3-OH group is highly oriented, consequently reducing the flexibility of N-sulfo
group. In light of these results, we are currently unable to conclusively determine whether
this N-sulfo group is required for substrate recognition.
Numerous amino acid residues have contacts with the carboxyl group of the iduronic acid
unit (I2). The amino acid residues include Lys161, Gln255, and Lys259 (Fig. 4c). In addition,
the 3-OH position lies well within hydrogen bonding distance of Arg190. Interestingly, the 2-
O-sulfo group is not positioned near any hydrogen bonding partners, yet it is reasonably well
ordered. The I2 unit is present in the 2S0 skew boat conformation, which differs from the
conformation of this saccharide bound to basic fibroblast growth factor (23). Recent work
has demonstrated the importance of the iduronic acid skew boat conformation in exhibiting
the anticoagulant activity (32).
The G1 unit is also present in a 4C1 conformation (Fig. 4c). The N-sulfo group interacts with
the side chain of Thr256 as well as with the side chains of Asp252, Trp283, and Ser284 (Table
IV). The 6-O-sulfo group makes no hydrogen bonding contacts with the protein.
Consequently, it is the most disordered group in the tetrasaccharide. Interestingly, a metal
ion modeled as a sodium ion appears to bind to the I2 and G1 units. The backbone carbonyl
and side chain of Asp252, as well as the side chain of Thr256, provide three of the ligands
coordinated to the metal (Fig. 4c, Table III). The other three ligand interactions, which
complete the octahedral coordination, are from the N-sulfo and 3-OH of the G1 unit as well
as a carboxylate oxygen atom of the I2 unit.
Determination of 3-O-Sulfonation Site on the Tetrasaccharide
To confirm the conclusions from the structural data, we proved that 3-OST-3 transfers the
[35S]sulfuryl group to the G3 unit (rather than to the G1 unit) when the tetrasaccharide is
used as a substrate. We prepared the 3-O-[35S]sulfated tetrasaccharide by incubating the
tetrasaccharide with purified 3-OST-3 enzyme and [35S]PAPS. We then identified the
[35S]sulfonation site of the resultant tetrasaccharide. This was determined by comparing
products of the heparin lyase digested 3-O-[35S]sulfated tetrasaccharide with and without
pretreatment of δ4,5-glycuronate-2-sulfatase as described under “Experimental Procedures.”
We observed that the product (δUA2S-[3-35S]GlcNS3S6S) of 3-O-[35S]sulfated
tetrasaccharide digested by heparin lyase was eluted at 38 min on the anion exchange HPLC
(Fig. 5C, dashed line), whereas the product (δUA-[3-35S]GlcNS3S6S) of the sulfatase-
pretreated sample was eluted at 25 min (Fig. 5C, solid line). Therefore, our data
demonstrated that the 3-O-[35S]sulfonation site is indeed on the G3 unit as predicted by the
crystal structure.
Catalytic Mechanism
The ternary structure of 3-OST-3/PAP/tetrasaccharide provides atomic details about the
reaction mechanism of HS sulfotransferases. When PAPS is superimposed onto PAP, the
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acceptor hydroxyl group of G3 is located 2.9 Å from the sulfur atom of PAPS and on the
opposite of the sulfur from the leaving group PAP (Fig. 6). The sulfonate group is easily
accommodated by the enzyme without rearrangement of side chain residues. The location of
the sulfonate group is consistent with a SN2-like in-line displacement mechanism. Given
that Glu184 is 2.8 Å from the 3-OH of the G3 unit (Fig. 4), it is reasonable to suppose that
this residue likely functions as a catalytic base, deprotonating the 3-OH for nucleophilic
attack on the sulfonate group. This glutamate residue is conserved among 3-OSTs and
NSTs, thereby suggesting an essential role for the catalytic function of HS sulfotransferases
(NSTs transfer the sulfuryl group to the amino position of a glucosamine unit within a HS
polysaccharide.). Indeed, mutations of this glutamate residue result in a complete loss of
sulfotransferase activities for NST-1 and 3-OST-1 (14, 16) and a 99.9% loss for 3-OST-3
(Table V).
A hydrogen bonding network that involves Glu184, His186, and Asp189 is observed in the
ternary complex (Fig. 6). The OE2 oxygen of Glu184 is 2.9 Å from the NE2 atom of His186.
The ND1 atom of His186 is 2.8 Å from OD2 of Asp189. This hydrogen bonding pattern is
reminiscent of a catalytic triad. The results of the mutational analysis demonstrated that
His186 and Asp189 are essential for the sulfotransferase activity (Table V). This hydrogen
bond network could either help properly position the glutamate for catalysis or serve as a
charge relay system to regulate the pKa of the glutamate. A similar hydrogen bond network
was also observed in 3-OST-1 but not in NST-1 (14, 15). Thus, the interactions within the
“triad” appear to be specific for 3-OSTs.
Mutational analysis
Site-directed mutagenesis experiments were performed to decipher the roles of the amino
acid residues in performing the catalytic functions and determining substrate specificity. The
results are summarized in Table V. We conducted the disaccharide analysis of the HS
modified by the mutants that maintain the sulfotransferase activity (catalytically active
mutants). Our data indicate that wild type protein and all of the catalytically active mutants
sulfonate identical disaccharide sequences (IdoUA2S-GlcNH2 and IdoUA2S-GlcNH26S;
see Fig. 1A for structures), suggesting that these mutants maintain wild type 3-OST-3
substrate specificity (data not shown). This conclusion is further strengthened by our
findings that none of the HS modified by the active mutants bind to antithrombin (data not
shown). This is consistent with our understanding that 3-OST-1-modified HS binds to
antithrombin, whereas 3-OST-3-modified HS does not (Fig. 1A).
Several mutations resulted in the loss of enzymatic activity (catalytically inactive mutants).
Among these, K162A, E184Q, H186F, and D189N are probably due to defects in catalytic
function. These conclusions are based on the crystal structural data as described above, as
well as our previous results of the characterization of corresponding 3-OST-1 mutants (14).
The roles of Lys215 and Arg370 are more complex. These two residues could be involved in
both binding to PAPS and substrate. Like Glu184 and Lys162, Lys215 and Arg370 are
conserved in the 3-OSTs and NST-1.
Two mutants, Q255A and K368A, are of special interest. Mutations at Gln255 and Lys368
nearly abolish sulfotransferase activity. However, mutations at the corresponding residues of
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3-OST-1, Q166A and K274A, maintain 34.0 and 17.4% of the sulfotransferase activity,
respectively (14). The data suggest that Gln255 and Lys368 contribute to the substrate
specificity of 3-OST-3. Indeed, the structural data indicate that the side chains of Gln255 and
Lys368 are within the hydrogen bonding distance to the carboxyl and 2-O-sulfo groups of the
U4 unit and the carboxyl group of the I2 unit as described above. This is consistent with the
fact that 3-OST-1 recognizes a disaccharide substrate (GlcUA-GlcNS±6S) that does not
contain the 2-O-sulfo group and the orientation of the carboxyl group of the GlcUA unit is
likely distinct from that of an iduronic acid unit (Fig. 1A).
Presently, we are unable to explain the mutation results for Lys194 and Lys366 because the
side chains of both residues do not interact with the tetrasaccharide. Residue Lys194 is
located over 14 Å from the tetrasaccharide. Residue Lys366 is located in a position where it
could interact with the nonreducing end of the oligosaccharide if one more sugar (a
glucosamine) were present, as is the case in the polymeric HS substrate used in the mutation
studies. Interestingly, in the x-ray crystal structure, Lys366 forms a lattice contact with the 6-
O-sufo group of G3 from a tetrasaccharide binding in a crystallographically related
molecule. This interaction does not appear to be bio-chemically relevant because the 6-O-
sulfo group is not required for 3-OST-3 activity (11), and the buried surface area between
the crystallographic interface of the two protein molecules is less than 3% of the total
surface area.
In summary, the structure of the 3-OST-3/PAP/tetrasaccharide has provided new insights
into the requirements for the substrate recognition by 3-OSTs and a more complete
description of the HS sulfotransferase mechanism. It appears that 3-OST-3 recognizes the
carboxyl and sulfo groups of the iduronic acid (U4) at the nonreducing end of the
glucosamine unit (G3) being sulfonated. The amino acid residues involved in binding to
these structural motifs are essential for the activity of 3-OST-3. This conclusion is consistent
with those from previous biochemical studies of 3-OSTs; 3-OST-1 sulfates a glucosamine
linked to a glucuronic acid unit at the nonreducing end, whereas 3-OST-3 sulfates the
glucosamine unit that is linked to a 2-O-sulfo iduronic acid unit at the nonreducing end (Fig.
1A) (9, 11, 17, 25). It is very important to note that the 3-OST-3 modification site is flanked
by two iduronic acid units in a skew boat like conformation. In contrast, the conformation of
the I2 unit is in the chair form in the fibroblast growth factor/tetrasaccharide complex (23).
It is likely that the conformation of the flanking iduronic acid residues contribute to
substrate recognition by 3-OST-3.
The 3-O-sulfonation of HS has been directly linked to the activities for regulating blood
coagulation and for promoting infection by HSV-1. Consequently elucidation of the general
mechanism and discovery of the atomic level requirements for specificity provide important
insight for understanding the biosynthesis of biologically active forms of HS.
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Fig. 1. Substrate specificities of 3-OST-1 and 3-OST-3 and the structure of the tetrasaccharide
substrate
A shows the enzymatic reactions catalyzed by 3-OST-1 and 3-OST-3. 3-OST-1 transfers
sulfate to the 3-OH position of a glucosamine unit (GlcNS±6S) that is linked to a glucuronic
acid unit (GlcUA), thereby forming the 3-O-sulfated HS containing GlcUA-GlcNS3S±6S
(an anticoagulant HS). 3-OST-3 transfers sulfate to the 3-OH position of a glucosamine unit
(GlcNH2±6S) that is linked to a 2-O-sulfo iduronic acid unit (IdoUA2S), thereby forming
the 3-O-sulfated HS containing IdoUA2S-GlcNH 3S±6S (an entry receptor for HSV-1). R
represents a proton (−H) or a sulfate group (−SOa− ). B shows the structure of the
tetrasaccharide used in the study. The 3-O-sulfonation site is circled. For clarity, U4
represents δUA2S; G3 represents GlcNS6S linked to δUA2S; I2 represents IdoUA2S; and
G1 represents GlcNS6S at the reducing end. The numbers indicate the positions of the
saccharide units.
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Fig. 2. Ribbon diagram of the crystal structure of ternary complex 3-OST-3/PAP (blue)/
tetrasaccharide (green) and sequence alignment of human 3-OST-3 and mouse 3-OST-1
β-Strands and α-helices are colored purple and cyan, respectively. This figure was created
using Molscript and Raster3d (33, 34). Structural alignment of 3-OST-3 with 3-OST-1 is
shown besides the ribbon diagram. Cyan barrels represent residues in helices, and purple
represents regions in β-strands. Residues that are structurally dissimilar are shaded with a
yellow background. Residues that form interactions with the tetrasaccharide are colored
green, and the cysteines that form a disulfide are colored orange. Red asterisks represent the
three residues that may form a catalytic triad in the 3-OSTs.
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Fig. 3. Stereo diagram of the PAPS binding site of 3-OST-3 with PAP bound (blue)
Residues that are within hydrogen bonding distance or that line the binding pocket are
pictured. Possible hydrogen bonds between the protein and the PAP are displayed as black
dashed lines. This figure was created using Molscript and Raster3d (33, 34).
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Fig. 4. Stereo diagrams of the binding of 3-OST-3 and tetrasaccharide
a, stereo diagram of HS acceptor substrate binding cleft with tetrasaccharide (green) bound.
Residues that line the cleft are pictured. Displayed in blue is the simulated annealing Fo – Fc
omit electron density map contoured at 2 σ. b, stereo diagram displaying the interactions
between 3-OST-3 and U4-G3 units. The O-3 oxygen of G3 unit is labeled. c, stereo diagram
of the interactions between 3-OST-3 and the I2-G1 units. A metal ion modeled as a sodium
ion is colored cyan, as are interactions between the metal and the coordinating atoms.
Possible hydrogen bonds between the protein and tetrasaccharide are displayed as black
dashed lines. These figures were created using Molscript and Raster3d (33, 34).
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Fig. 5. Anion exchange HPLC chromatograms of enzymatic digested and undigested 3-O-
[35S]sulfated tetrasaccharide
A and B show the chromatogram of 3-O-[35S]sulfated tetrasaccharide without and with δ4,5-
glycuronate-2-sulfatase digestion, respectively. C shows the chromatogram of heparin lyases
digested 3-O-[35S]sulfated tetrasaccharide that was treated with δ4,5-glycuronate-2-sulfatase
(solid line) and the chromatogram of the heparin lyases digested 3-O-[35S]sulfated
tetrasaccharide without the treatment of δ4,5-glycuronate-2-sulfatase (dashed line). The
enzymatic digestion reactions are illustrated besides the chromatograms. The anion
exchange HPLC was performed on a silica based amino-bound anion exchange HPLC (0.46
× 24 cm; Waters) eluted with a linear gradient of KH2PO4 (300 –1000 mM in 60 min)
followed by 1 M KH2PO4 for additional 20 min at a flow rate of 0.5 ml/min. Arrow 1,
elution position of [35S]sulfate; arrow 2, elution position of δUA-[3-35S]GlcNS3S6S; arrow
3, elution position of δUA2S-[3-35S]GlcNS3S6S; arrow 4, elution position of δUA-
[3-35S]GlcNS3S6S-IdoUA2S-GlcNS6S; arrow 5, elution position of δUA2S-
[3-35S]GlcNS3S6S-IdoUA2S-GlcNS6S.
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Fig. 6. Active site of 3-OST-3 with PAPS superimposed
Stereo diagram of the superposition of the PAPS (orange) from the crystal structure of
human estrogen sulfotransferase into the active site of 3-OST-3 (30). The superposition is
based on the Cα atoms of the phosphosulfate-binding loop and selected atoms of the PAP
and PAPS molecules (O-5′, C-5′, C-4′, C-3′, and the 5′phosphate). The PAP (blue) and the
acceptor G3 (green) are pictured, as are the residues that may play a catalytic role. Possible
hydrogen bonds between 3-OST-3 and its substrate are displayed as black dashed lines.
Possible interactions between 3-OST-3 and the donor sulfuryl group based on the
superposition are displayed as pink dashed lines. Also displayed as a pink dashed line is the
line of attack of the O-3 oxygen of the sugar to the sulfur atom of the PAPS molecule. This
figure was created using Molscript and Raster3d.
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Table I
Crystallographic data statistics
Data set 3-OST-3 and PAP 3-OST-3 and tetrasaccharide and PAP
Unit cell a = 80.34, b = 155.39, c = 92.32 a = 80.81, b = 154.53, c = 91.93
α = β = γ = 90° α = β = γ = 90°
Space group C222(1) C222(1)
Resolution (Å) 50–1.85 50-1.95
Number of observations 183,877 160,766
Unique reflections 49,160 42,327
Rsvm (%) (last shell)
a 11.0 (29.7) 5.4 (39.3)
I/σ (I) (last shell) 23.1 (3.5) 18.2 ( 2.4)
Mosaicity 0.7 0.7






 Number of waters 422 333
 Average B values (Å)
  Protein 29.1 27.9
  PAP 20.2 17.9
  Tetrasaccharide 43.1
Root mean square deviation from ideal values
d
 Bond length (Å) 0.006 0.006
 Bond angle (°) 1.2 1.2
 Dihedral angle (°) 21.2 21.0
 Improper angle (°) 0.87 0.79
Ramachandran statistics
d
 Residues in favored (98%) regions (%) 97.56 97.94
 Residues in allowed (>99.8%) regions (%) 100 100
a
Rsym = Σ (Ii – ⟨I⟩/Σ(Ij) where Ij is the intensity of the ith observation and ⟨I⟩ is the mean intensity of the reflection.
b
Rcryst = Σ||Fo – Fc calculated from working data set.
c
Rfree was calculated from 5% of data randomly chosen not to be included in refinement.
d
The Ramachandran results were determined by MolProbity (35).
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Table II
Distances of potential hydrogen bonds between PAP and 3-OST-3 protein
PAP Protein contact Distance
Å
5′P
 O6P Lys162 NZ 2.8
 O6P Lys368 NZ 3.1
 O5P Lys368 NZ 2.7
 O5P Arg166 N 3.1
 O4P Thr165 OG1 2.7
 O4P Thr165 N 2.8
 O4P Gly164 N 3.2
 O5′ Gly164 N 3.1
3′P
 O3′ Arg243 NH1 3.0
 O2P His372 NE2 2.6
 O2P Ser251 OG 2.6
 O3P Arg370 N 2.8
 O3P Gly369 N 2.9
 Ade N6 Pro350 O 2.9
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Table III
Distances of potential interactions with the metal ion
Ion Protein contact Distance
Å
NA+1 I2 O62 2.7
NA+1 G1 2N O3S 2.4
NA+1 G1 3OH 2.5
NA+1 Asp252 O 2.5
NA+1 Thr256 OG1 2.3
NA+1 Asp252 OD1 2.4
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Table IV
Distances of potential hydrogen bonds between the tetrasaccharide and 3-OST-3 protein
Saccharide Protein contact Distance
Å
U4
 2 O1S Lys259 NZ 2.9
 2 O1S Gln255 NE2 3.0
 2 O3S Arg370 NH2 2.7
 2 O3S Gln255 OE1 3.1
 6 O61 Lys368 NZ 2.7
 6 O61 Lys215 NZ 2.7
 6 O62 Arg166 NE 2.7
 6 O62 Arg166 NH2 2.5
 3 OH Thr367 OG1 2.6
G3
 2 N O2S Ser218 N 3.0
 2 N O6S Lys366 NZ
a 2.5
 6 O4S Lys259 NZ 2.9
 O6 Lys259 NZ 3.1
 3 OH Glu184 OE2 2.8
 3 OH H2O 158 3.0
I2
 3 OH Arg190 NH2 2.6
 6 O61 Lys259 NZ 2.6
 6 O61 Gln255 NE2 2.6
 6 O62 Lys161 NZ 2.6
G1
 2 N Thr256 OG1 2.9
 2 N O1S Ser284 OG 2.9
 2 N O1S Trp283 NE1 2.9
 2 N O3S Asp252 OD1 2.8
a
This residue is from a crystallographic symmetry related protein molecule in the crystal lattice.
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Table V
Summary of the analysis of the sulfotransferase activity of 3-OST-3 mutants







3-OST-3 wild type 100 + +
3-OST-3 K161A 0.4 +
3-OST-3 K162A 0.4 +
3-OST-3 R166E 0.2 + +
3-OST-3 E170Q 83 + +
3-OST-3 R173S 55.9 + + +
3-OST-3 G182A 106 + +
3-OST-3 E184Q 0.1 + +
3-OST-3 H186F 0.0 +
3-OST-3 D189N 0.9 +
3-OST-3 R190E 68 + +
3-OST-3 K194A 0.5 +
3-OST-3 K215A 0.1 + + +
3-OST-3 S218A 76.7 + +
3-OST-3 E224Q 52.4 + +
3-OST-3 Q255A 0.4 + +
3-OST-3 K259A 51.7 + +
3-OST-3 I288A 35 + +
3-OST-3 K293A 66.4 + +
3-OST-3 H362A 101.5 + +
3-OST-3 G365A 57 + +
3-OST-3 K366A 0.2 + +
3-OST-3 K368A 0.1 + +
3-OST-3 R370E 0.8 + +
a
The mutants were prepared using a site-directed mutagenesis kit from Invitrogen.
b
The activity of 3-OST-3 was assayed by incubating the purified mutant proteins with HS and [35S]PAPS, and the resultant [35S]HS was
quantified by a DEAE chromatography, where 100% activity represents the transfer of 18 pmol of sulfate/μg of protein under the standard assay
condition.
c
The expression level of the proteins was determined by the intensity of the Coomassie Blue-stained protein band migrated at 30 kDa on SDS-
PAGE.
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